Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Epitope mapping: the first step in developing epitope-based vaccines.

Jonathan M Gershoni1, Anna Roitburd-Berman, Dror D Siman-Tov

  • 1Department of Cell Research and Immunology, Tel Aviv University, Tel-Aviv, Israel. gershoni@tauex.tau.ac.il

Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|May 23, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Serum-antibody Profiling of H3N2-infected Ferrets Using a Combinatorial Phage-display Random Peptide Library.

Journal of molecular biology·2026
Same author

Gene therapies for neurogenetic disorders.

Trends in molecular medicine·2025
Same author

A comparison of automatic and manual measures of turn-taking in monolingual and bilingual contexts.

Behavior research methods·2023
Same author

Parentese in infancy predicts 5-year language complexity and conversational turns.

Journal of child language·2023
Same author

Language input in late infancy scaffolds emergent literacy skills and predicts reading related white matter development.

Frontiers in human neuroscience·2022
Same author

Antibody Recognition of CD4-Induced Open HIV-1 Env Trimers.

Journal of virology·2022
Same journal

Ustekinumab Biosimilars versus Reference Ustekinumab for Moderate-to-Severe Plaque Psoriasis: A Pre-switch Systematic Review and Meta-analysis.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2026
Same journal

Correction: Mirikizumab as Induction and Maintenance Therapy in Chinese Patients with Ulcerative Colitis: A Subpopulation Analysis of the Randomized, Global Phase 3 LUCENT-1 and LUCENT-2 Trials.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2026
Same journal

Gene Therapy Strategies for Uveal Melanoma: Adeno-associated Virus Delivery Challenges and Translational Opportunities.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2026
Same journal

Review of Quality Attributes and Analytical Methods Used for Comparative Analytical Assessment of Monoclonal Antibodies as Part of Successful Biosimilar Approvals in the United States and European Union.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2026
Same journal

Impact of Repeated Antigen Exposure on Humoral Tolerance: Antidrug Antibodies After Single-Dose Versus Multi-dose Adalimumab.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2026
Same journal

An Overview and Trend Analysis of Biosimilar Approvals in China.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2026
See all related articles

Discovering antibody epitopes is key for designing effective vaccines. This study explores methods to identify specific epitopes from antibodies, enabling the development of targeted B-cell epitope-based vaccines for infectious diseases.

Area of Science:

  • Immunology
  • Vaccinology
  • Structural Biology

Background:

  • Antibodies neutralize pathogens by recognizing specific epitopes on antigens.
  • Understanding antibody-epitope interactions is crucial for rational vaccine design.
  • B-cell epitope-based vaccines aim to elicit potent neutralizing antibodies.

Purpose of the Study:

  • To review methods for epitope discovery based on specific antibodies.
  • To outline a reversed immunological approach for epitope-based vaccine development.
  • To discuss the advantages and limitations of various epitope mapping techniques.

Main Methods:

  • X-ray crystallography of antigen:antibody complexes (gold standard).
  • Antigen mutagenesis to identify critical epitope residues.

Related Experiment Videos

  • Computational combinatorial methods, including phage display peptide libraries.
  • Development of algorithms like Mapitope for epitope mapping.

    • Main Results:

    • X-ray crystallography provides atomic resolution but is technically demanding.
    • Mutagenesis and computational methods offer alternative approaches for epitope identification.
    • Phage display and algorithms like Mapitope are effective for mapping conformational epitopes.

    Conclusions:

    • Epitope discovery from antibodies is essential for developing targeted vaccines.
    • A range of methods exists, each with specific applications and limitations.
    • Reversed immunological approaches facilitate rational vaccine design.